LONG TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

被引：0
|
作者：
Parisi, M. [1 ]
Conticello, C. [1 ]
Leotta, S. [1 ]
Martino, E. [1 ]
Calafiore, V [1 ]
Del Fabro, V [1 ]
Pirosa, M. C. [1 ]
Romano, A. [1 ]
Di Raimondo, F. [1 ]
机构：
[1] Univ Catania, Div Hematol, AO Policlin Vittorio Emanuele, Catania, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P51
引用
下载
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience
    Conticello, Concetta
    Parisi, Marina
    Leotta, Salvatore
    Parrinello, Nunziatina Laura
    Martino, Enrica
    Calafiore, Valeria
    Pirosa, Maria Cristina
    Markovic, Urosh
    Romano, Alessandra
    Di Raimondo, Francesco
    BLOOD, 2018, 132
  • [2] Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
    Parisi, Marina Silvia
    Leotta, Salvatore
    Romano, Alessandra
    Del Fabro, Vittorio
    Martino, Enrica Antonia
    Calafiore, Valeria
    Giubbolini, Rachele
    Markovic, Uros
    Leotta, Valerio
    Di Giorgio, Mary Ann
    Tibullo, Daniele
    Di Raimondo, Francesco
    Conticello, Concetta
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [3] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [4] Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
    Canto, Chiara
    Ranucci, Elena
    Pulini, Stefano
    Santoleri, Fiorenzo
    Morelli, Anna Maria
    Fioritoni, Francesca
    Falorio, Simona
    Torti, Lorenza
    Spadano, Antonio
    D'Aloisio, Marianna
    Di Ianni, Mauro
    Santarone, Stella
    Di Bartolomeo, Paolo
    BLOOD, 2018, 132
  • [5] Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
    Shah, Jatin
    Usmani, Saad
    Stadtmauer, Edward A.
    Rifkin, Robert M.
    Berenson, James R.
    Berdeja, Jesus G.
    Lyons, Roger M.
    Klippel, Zandra
    Chang, Yu-Lin
    Niesvizky, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (09): : 570 - +
  • [6] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Dharshan Sivaraj
    Michael M Green
    Yubin Kang
    Gwynn D Long
    David A Rizzieri
    Zhiguo Li
    Anderson H Garrett
    Jackie L McIntyre
    Nelson J Chao
    Cristina Gasparetto
    Blood Cancer Journal, 8
  • [7] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Kang, Yubin
    Long, Gwynn D.
    Rizzieri, David A.
    Li, Zhiguo
    Garrett, Anderson H.
    McIntyre, Jackie L.
    Chao, Nelson J.
    Gasparetto, Cristina
    BLOOD CANCER JOURNAL, 2018, 8
  • [8] Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Bahlis, Nizar
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea C.
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    Leblanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie Scott
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2019, 134
  • [9] Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma
    Jandial, Aditya
    Mishra, Kundan
    Lad, Deepesh
    Prakash, Gaurav
    Khadwal, Alka
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1102 - 1104
  • [10] Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience
    Zherebtsova, Vera A.
    Vorobyev, Vladimir, I
    Gemdzhian, Eduard G.
    Ulyanova, Margarita A.
    Chernikov, Mikhail, V
    Ivanova, Valentina L.
    Vinogradova, Olga Yu
    Ptushkin, Vadim V.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (07): : 785 - 792
12345